Xiaobu Ye
Impact in
Papers in
- Co-authors
- Stuart A. Grossman (82 shared papers)Serena Desideri (38 shared papers)Steven Piantadosi (6 shared papers)Jian Campian (13 shared papers)Joy Fisher (27 shared papers)Michael Lim (16 shared papers)Myrna R. Rosenfeld (6 shared papers)Jaishri O. Blakeley (13 shared papers)
- Journals
- Neuro-Oncology (21 papers)Journal of Clinical Oncology (20 papers)Journal of Neuro-Oncology (18 papers)Clinical Cancer Research (7 papers)Neurosurgery (6 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Xiaobu Ye
142 papers receiving 6.9k citations
Xiaobu Ye's Hit Papers
Peers
Comparison fields: 5 of 137
- Genetics 1.9k
- Oncology 2.3k
- Immunology 1.1k
- Cancer Research 648
- Neurology 521
Countries citing papers authored by Xiaobu Ye
This map shows the geographic impact of Xiaobu Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobu Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobu Ye more than expected).
Fields of papers citing papers by Xiaobu Ye
This network shows the impact of papers produced by Xiaobu Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobu Ye. The network helps show where Xiaobu Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobu Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide Hit paper breakdown → | 2011 | 421 |
| 2 | A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme Hit paper breakdown → | 2014 | 420 |
| 3 | Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma Hit paper breakdown → | 2013 | 378 |
| 4 | 2010 | 363 | |
| 5 | 2015 | 274 | |
| 6 | Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Hit paper breakdown → | 2017 | 249 |
| 7 | 2015 | 244 | |
| 8 | 2015 | 241 | |
| 9 | 2016 | 239 | |
| 10 | 2014 | 184 | |
| 11 | 2009 | 181 | |
| 12 | 2009 | 181 | |
| 13 | 2013 | 177 | |
| 14 | 2015 | 173 | |
| 15 | 2013 | 173 | |
| 16 | 2013 | 144 | |
| 17 | 2009 | 131 | |
| 18 | 2012 | 123 | |
| 19 | 2008 | 111 | |
| 20 | 2013 | 111 |
About Xiaobu Ye
Xiaobu Ye is a scholar working on Genetics, Oncology, Neurology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 152 papers that have together received 6.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (62 papers), Brain Metastases and Treatment (15 papers), Cancer Immunotherapy and Biomarkers (14 papers), Inflammatory Biomarkers in Disease Prognosis (11 papers), Cancer, Hypoxia, and Metabolism (9 papers), Cancer Treatment and Pharmacology (8 papers), PARP inhibition in cancer therapy (7 papers) and Multiple Myeloma Research and Treatments (6 papers). The work is most often cited by research in Genetics (1.9k citations), Oncology (2.3k citations), Immunology (1.1k citations), Cancer Research (648 citations) and Neurology (521 citations). Xiaobu Ye has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Stuart A. Grossman, Serena Desideri, Steven Piantadosi, Jian Campian, Joy Fisher, Michael Lim, Myrna R. Rosenfeld, Jaishri O. Blakeley, Glenn J. Lesser and Burt Nabors. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Journal of Neuro-Oncology, Clinical Cancer Research and Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.